Literature DB >> 16487370

HMB45+ cells in mixed stromal-smooth muscle tumour of the uterus.

M Zamecnik, L Voltr, A Chlumska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16487370     DOI： 10.1111/j.1365-2559.2005.02251.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

Review 1.  Mixed endometrial stromal and smooth muscle tumor with heart metastasis: report of a case and review of literature.

Authors:  Chenghui Huang; Haihua Zhu; Cong Xu; Sophia Jennie Ferrance; Peiguo Cao; Qi Wang; Jingjing Li; Zhen Zhang; Fang Xia; Xiaowei Peng; Ke Cao
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Authors:  Sarah Chiang; Wesley Samore; Lei Zhang; Yun-Shao Sung; Gulisa Turashvili; Rajmohan Murali; Robert A Soslow; Martee L Hensley; David Swanson; Brendan C Dickson; Colin J R Stewart; Esther Oliva; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

3.  Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.

Authors:  Jennifer A Bennett; Ana C Braga; Andre Pinto; Koen Van de Vijver; Kristine Cornejo; Anna Pesci; Lei Zhang; Vicente Morales-Oyarvide; Takako Kiyokawa; Gian Franco Zannoni; Joseph Carlson; Tomas Slavik; Carmen Tornos; Cristina R Antonescu; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

4.  Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.

Authors:  Pier Selenica; Niamh Conlon; Carlene Gonzalez; Denise Frosina; Achim A Jungbluth; Regina G H Beets-Tan; Mamta K Rao; Yanming Zhang; Ryma Benayed; Marc Ladanyi; David B Solit; Sarah Chiang; David M Hyman; Martee L Hensley; Robert A Soslow; Britta Weigelt; Rajmohan Murali
Journal:  Am J Surg Pathol       Date:  2021-01       Impact factor: 6.394
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.